Key facts
- It has raised $500K; the latest was Early Stage VC ($500K) in Jul 2025.
- Notable investors include LaunchVic, Breakthrough Victoria, Cooperative Research Centres Projects, Department of Jobs, Genesis Pre-Seed Fund — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Remagine Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Remagine Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Remagine Labs
Developer of wearable drug delivery systems designed for epilepsy treatment. The company's system offers a non-invasive and controlled method of delivering epilepsy medication, reducing the risk of missed doses and side effects, enabling patients to manage their condition more effectively, improving quality of life, and reducing the economic burden associated with epilepsy.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2001
- Employees
- 3
- Website
- remaginelabs.com/
- Ownership
- Privately Held (backing)
Remagine Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Remagine Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Remagine Labs in its N-PORT filings yet. We sweep new filings monthly.